Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-009683
Filing Date
2022-04-12
Accepted
2022-04-12 15:54:40
Documents
60
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1038475
2 ex31-1.htm EX-31.1 18739
3 ex32-1.htm EX-32.1 7591
4 aud_001.jpg GRAPHIC 3371
5 aud_002.jpg GRAPHIC 2299
  Complete submission text file 0001493152-22-009683.txt   4991611

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gcan-20211231.xsd EX-101.SCH 39717
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gcan-20211231_cal.xml EX-101.CAL 47411
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gcan-20211231_def.xml EX-101.DEF 204778
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gcan-20211231_lab.xml EX-101.LAB 304350
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gcan-20211231_pre.xml EX-101.PRE 268558
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 670918
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56027 | Film No.: 22822197
SIC: 2834 Pharmaceutical Preparations